Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CUPISSOL D")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 60

  • Page / 3
Export

Selection :

  • and

EPANCHEMENTS PLEURAUX: TRAITEMENT LOCAL PAR CORYNEBACTERIUM PARVUMSERROU B; CUPISSOL D.1980; NOUV. PRESSE MED.; FRA; DA. 1980; VOL. 9; NO 25; PP. 1777-1778; BIBL. 4 REF.Article

IMMUNE IMBALANCE AND IMMUNE MODULATION IN SOLID TUMOR PATIENTS: NEW INSIGHTSSERROU B; CUPISSOL D; ROSENFELD C et al.1982; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1982; NO 80; PP. 9-16; BIBL. 28 REF.Article

PLASMA TRANSFERABLE INHIBITION OF BCG INDUCED SUBCUTANEOUS INFLAMMATION IN HUMAN CANCERBUREAU JP; SENELAR R; CUPISSOL D et al.1981; J. PATHOL.; ISSN 0022-3417; GBR; DA. 1981; VOL. 133; NO 3; PP. 215-227; BIBL. 2 P.Article

MODULATION DE L'ACTIVITE SUPPRESSIVE PAR LA THYMOSINECUPISSOL D; THIERRY C; SERROU B et al.1981; C.R. SOC. BIOL. FIL.; ISSN 0037-9026; FRA; DA. 1981; VOL. 175; NO 2; PP. 235-241; ABS. ENG; BIBL. 10 REF.Article

ABILITY OF LYMPHOCYTES TREATED WITH THYMIC FACTOR TO DECREASE LUNG METASTASIS IN TUMOR-BEARING MICECUPISSOL D; TOURAINE JL; SERROU B et al.1981; THYMUS; ISSN 0165-6090; NLD; DA. 1981; VOL. 3; NO 1; PP. 9-16; BIBL. 15 REF.Article

DECREASE OF TUMOR GROWTH IN MICE AFTER INTRAVENOUS THYMOSIN-TREATED BONE MARROW CELL INJECTION = DIMINUTION DE LA CROISSANCE TUMORALE CHEZ LA SOURIS APRES INJECTION INTRAVEINEUSE DE CELLULES DE MOELLE OSSEUSE TRAITEE PAR THYMOSINECUPISSOL D; REY A; GOLDSTEIN AL et al.1982; JOURNAL OF THE NATIONAL CANCER INSTITUTE; ISSN 0027-8874; USA; DA. 1982; VOL. 69; NO 1; PP. 27-31; ABS. ENG; BIBL. 42 REF.; GRAPHArticle

DOUBLE-BLIND STUDY OF CIPROPRIDE VERSUS PLACEBO IN CANCER CHEMOTHERAPY-INDUCED VOMITINGCOQUELIN JP; NARBONNE G; SERROU B et al.1983; CURRENT THERAPEUTIC RESEARCH; ISSN 0011-393X; USA; DA. 1983; VOL. 33; NO 5; PP. 816-827; BIBL. 16 REF.Article

EVALUATION D'UN NOUVEL ANTI-EMETIQUE, L'ALIZAPRIDE, EN CANCEROLOGIECUPISSOL D; FAVIER F; FAVIER C et al.1982; SEMAINE DES HOPITAUX; ISSN 0037-1777; FRA; DA. 1982; VOL. 58; NO 22; PP. 1370-1373; ABS. ENG; BIBL. 12 REF.Article

Progrès récents de la couverture anti-émétique nécessaire en cancérologie = Progress in antiemetic use in cancerologyCUPISSOL, D; SERROU, B.La Semaine des hôpitaux de Paris. 1984, Vol 60, Num 36-37, pp 2569-2571, issn 0037-1777Article

PROGNOSTIC EVALUATION OF HUMAN TUMOR CELL IN VITRO CLONING ASSAYREY A; CUPISSOL D; FAVIER F et al.1982; BIOMEDICINE; ISSN 0300-0893; FRA; DA. 1982; VOL. 36; NO 1; PP. 42-45; ABS. FRE; BIBL. 19 REF.Article

Le mélanome métastatique = Metastatic melanomaCUPISSOL, D; GUILLOT, B.Oncologie (Paris). 2000, Vol 2, Num 1, pp 60-67, issn 1292-3818Article

Immune complexes in patients bearing solid tumorsCUPISSOL, D; THIERRY, C; SERROU, B. C et al.Contemporary topics in immunobiology. 1985, Vol 15, pp 139-146, issn 0093-4054Article

CIPROPRIDE IN PREVENTING NAUSEA AND VOMITING INDUCED BY SEVERELY EMETIC CYTOSTATIC AGENTSSERROW B; CUPISSOL D; ROSENFELD C et al.1981; J. INT. MED. RES.; ISSN 0300-0605; GBR; DA. 1981; VOL. 9; NO 5; PP. 390-391; BIBL. 3 REF.Article

The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesisCUPISSOL, D. R; SERROU, B; CAUBEL, M et al.European journal of cancer & clinical oncology. 1990, Vol 26, pp S23-S27, issn 0277-5379, suppl. 1Conference Paper

FOLLOW-UP OF A RANDOMIZED TRIAL FOR OAT CELL CARCINOMA EVALUATING THE EFFICACY OF PERIPHERAL INTRAVENOUS NUTRITION (PIVN) AS ADJUNCT TREATMENTSERROU B; CUPISSOL D; PLAGNE R et al.1982; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1982; NO 80; PP. 246-253; BIBL. 32 REF.Article

IMMUNE IMBALANCE IN CANCER PATIENTSSERROU B; GAUCI L; CARAUX J et al.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 75; PP. 41-46; BIBL. 12 REF.Article

ABILITY OF THYMOSIN TO DECREASE IN VIVO AND IN VITRO SUPPRESSOR CELL ACTIVITY IN TUMOR BEARING MICE AND CANCER PATIENTSSERROU B; CUPISSOL D; CARAUX J et al.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 75; PP. 110-114; BIBL. 14 REF.Article

LA NUTRITION PARENTERALE EN TANT QU'ADJUVANT THERAPEUTIQUE: RESULTATS A 30 MOIS D'UN ESSAI RANDOMISE POUR LES MALADES PORTEURS DE CANCERS ANAPLASIQUES DES BRONCHES = PARENTERAL NUTRITION AS A THERAPEUTIC ADJUVANT: 30 MONTH RESULTS OF RANDOMISED STUDY OF PATIENTS WITH ANAPLASTIC BRONCHIAL CANCERSERROU B; CUPISSOL D; REY A et al.1983; BULLETIN DU CANCER; ISSN 0007-4551; FRA; DA. 1983; VOL. 70; NO 2; PP. 84-87; BIBL. 19 REF.; GRAPHArticle

Increased sensitivity of IL2-dependent cultured T cells and enhancement of in vitro IL2 production by human lymphocytes treated with bestatinNOMA, T; KLEIN, B; CUPISSOL, D et al.International journal of immunopharmacology. 1984, Vol 6, Num 2, pp 87-92, issn 0192-0561Article

Marqueurs pharmacologiques prédictifs de la neutropénie chimioinduite par le cisplatine (CDDP) = Predictive pharmacological markers of cisplatin (CDDP) induced neutropenia in cancer patientsGORY-DELABAERE, G; CUPISSOL, D; BRES, J et al.Journal de la Société de biologie. 1999, Vol 193, Num 1, pp 49-55, issn 1295-0661Article

Chemotherapy in carcinomas of unknown primary site : A high-dose intensity policyCULINE, S; FABBRO, M; YCHOU, M et al.Annals of oncology. 1999, Vol 10, Num 5, pp 569-575, issn 0923-7534Article

Subcutaneous interleukin-2 and interferon-alpha therapy associated with cisplatin monochemotherapy in the treatment of metastatic melanomaANDRES, P; CUPISSOL, D; GUILLOT, B et al.EJD. European journal of dermatology. 1998, Vol 8, Num 4, pp 235-239, issn 1167-1122Article

Validation d'une méthode de dosage de la vinorelbine (Navelbine®) par CLHP dans la salive : concentrations chez le patient cancéreux = HPLC saliva vinorelbine (Navelbine®) assay validation : concentrations in cancer patientsGAU, F; BRES, J; CUPISSOL, D et al.Journal de pharmacie clinique (Paris). 1999, Vol 18, Num OCT, pp 62-64, issn 0291-1981, NSConference Paper

A double-blind, randomised, crossover comparison of granisetron and ondansetron in 5-day fractionated chemotherapy : assessment of efficacy, safety and pateint preferenceNOBLE, A; BREMER, K; GOEDHALS, L et al.European journal of cancer. Part A. 1994, Vol 30, Num 8, pp 1083-1088Article

En région Languedoc-Roussillon, un programme d'aide à l'arrêt du tabac pour les personnes en situation de handicapSTOEBNER-DELBARRE, A; HUTEAU, M.E; BAEZA-VELASCO, C et al.LA SANTE EN ACTION. 2013, Num 426, pp 14-16, 3 p.Article

  • Page / 3